References
- Adams JM. Primary virus pneumonitis with cytoplasmic inclusion bodies: a study of an epidemic involving thirty-two infants with nine deaths. J Am Med Assoc 1941;116:925-33
- Morris JA, Blount RE, Savage RE. Recovery of cytopathogenic agent from chimpanzees with coryza. Proc Soc Exp Biol Med 1956;92:544-9
- Chanock RM, Kim HW, Vargosko AJ, et al. Respiratory syncytial virus. 1. Virus recovery and other observations during the 1960 outbreak of bronchiolitis, pneumonia, and minor respiratory diseases in children. JAMA 1961;176:647-53
- Meissner HC. Viral bronchiolitis in children. N Engl J Med 2016;374:62-72
- Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med 2009;360:588-98
- Nair H, Nokes DJ, Gessner BD, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010;375:1545-55
- Deshpande SA, Northern V. The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defined geographical area. Arch Dis Child 2003;88:1065-9
- Simon A, Müller A, Khurana K, et al. DSM RSV Paed Study Group. Nosocomial infection: a risk factor for a complicated course in children with respiratory syncytial virus infection – results from a prospective multicenter German surveillance study. Int J Hyg Envir Heal 2008;211:241-50
- Sanchez-Luna P, Elola FJ, Fernandez-Perez C, et al. Trends in RSV bronchiolitis hospitalizations in children less than 1 year: 2004–2012. Curr Med Res Opin 2016;32;693-9
- Smyth RL, Openshaw PJ. Bronchiolitis. Lancet 2006;368:312-22
- Fleming DM, Pannell RS, Cross KW. Mortality in children from influenza and respiratory syncytial virus. J Epidemiol Community Health 2005;59:586-90
- Byington CL, Jacob Wilkes J, Korgenski K, et al. Respiratory syncytial virus–associated mortality in hospitalized infants and young children. Pediatrics 2015;135:e24-31
- Thorburn K. Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection. Arch Dis Child 2009;94:99-103
- Welliver RC. Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection. J Pediatr 2003;143:S112-17
- Handforth J, Friedland JS, Sharland M. Basic epidemiology and immunopathology of RSV in children. Paediatr Respir Rev 2000;1:210-14
- Shay DK, Holman RC, Roosevelt GE, et al. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979–1997. J Infect Dis 2001;183:16-22
- Thorburn K, Eisenhut M, Riordan A. Mortality and morbidity of nosocomial respiratory syncytial virus (RSV) infection in ventilated children – a ten year perspective. Minerva Anestesiol 2012;78:782-6
- Murray J, Bottle A, Sharland M, et al. Medicines for Neonates Investigator Group. Risk factors for hospital admission with RSV bronchiolitis in England: a population-based birth cohort study. PLoS One 2014;9:e89186
- Andabaka T, Nickerson JW, Rojas-Reyes MX, et al. Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children. Cochrane Database Syst Rev 2013;4:CD006602
- American Academy of Pediatrics Committee on Infectious Diseases; American Academy of Pediatrics Bronchiolitis Guidelines Committee. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics 2014;134:415-20
- Collins PL, Fearns R, Graham BS. Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease. Curr Top Microbiol Immunol 2013;372:3-38
- Melero JA, Moore ML. Influence of respiratory syncytial virus strain differences on pathogenesis and immunity. Curr Top Microbiol Immunol 2013;372:59-82